Hangzhou, China · Founded 2019 · Privately Held (backing)
Manufacturer of macromolecular antibody drugs focused on integrated biopharmaceutical research and production. I-Mab (Hangzhou) is based in Hangzhou, China and was founded in 2019. It has raised $154 million.
Last price · $/share
—
Implied valuation
—
Total raised
$154.3M
Last round
—
Cap table — not yet on record
I-Mab (Hangzhou)'s share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of I-Mab (Hangzhou) with a free account
·The complete investor list: 23 names
·Watch I-Mab (Hangzhou): the Monday email on marks, rounds and moves
